PhRMA launches new campaign to improve diabetes awareness

4 December 2006

With nearly 21 million people in the USA suffering from diabetes and as many as 6.2 million unaware that they have the disease, the Pharmaceutical Research and Manufacturers of America (PhRMA) has launched a new national health education campaign on diabetes awareness.

"Diabetes is taking a terrible toll on patients and their families," said Billy Tauzin, chief executive of the PhRMA, citing data from the American Diabetes Association. He added that "as many as 7% of all Americans suffer from diabetes and millions don't know they have the disease. Because early diagnosis can improve treatment outcomes, it is clear that education is important for patients. Knowledge and early action can often help turn diabetes into a more manageable disease."

The PhRMA's new public service campaign will stress the importance of patients consulting with their health care providers. It will also promote web sites where they can find answers about prevention and the latest advances in treatments. The new campaign, supported by national newspaper and television advertising in addition to new Internet-based materials and radio segments, will provide information in central, easy-to-find locations.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight